Abstract: The invention consists of a new formulation of ibuprofen and codeine in the form of a tablet, which comprises L-leucine in a concentration ranging between 4%-15% as a lubricant, in order to prevent the formulation mixture from adhering to the punches and to other elements of the compression machine during the compression process. The new formulation additionally comprises talc (0.5%-5.0%) and silicified microcrystalline cellulose (30%-80%). The formulation is preferably arranged in the form of a core that comprises the active principles and, amongst others, the L-leucine, part of the talc and the silicified microcrystalline cellulose; this core is coated with a composition that contains a copolymer of methacrylic acid and ethyl acrylate.
Type:
Grant
Filed:
April 23, 2008
Date of Patent:
July 23, 2013
Assignee:
Farmasierra Manufacturing, S.L.
Inventors:
María Rosario Fernández De Gatta García, Eduardo Jáudenes Salazar, Tomás Olleros Izard
Abstract: Pharmaceutical formulation based on ibuprofen and codeine having improved stability. The invention consists of a novel pharmaceutical formulation having the form of tablets or similar comprising a core composed of an association of ibuprofen and codeine as active ingredients, together with an excipient including at least a diluent, a disintegrating agent, a fluidizing agent and a lubricant which is sodium stearyl fumarate. Said core is coated with a composition based on one or several polymers of diverse modified cellulose ethers and polymers derived from acrylic and methacrylic acids, a plasticiser and, an opacifier or colouring agent and any of the mixtures thereof. These characteristics render the tablets of the invention more efficacious and safe having the form of more stable preparations, without this fact implying greater technological complexity.
Type:
Application
Filed:
March 25, 2011
Publication date:
March 14, 2013
Applicant:
FARMASIERRA MANUFACTURING, S.L.
Inventors:
Carmen Trives Lombardero, Luis Alberto Del Río Álvarez, Nuria Salazar Sánchez, Eduardo Jáudenes Salazar, Tomás Olleros Izard, Mª Rosario Fernández De Gatta García
Abstract: The invention consists of a new formulation of ibuprofen and codeine in the form of a tablet, which comprises L-leucine in a concentration ranging between 4%-15% as a lubricant, in order to prevent the formulation mixture from adhering to the punches and to other elements of the compression machine during the compression process. The new formulation additionally comprises talc (0.5%-5.0%) and silicified microcrystalline cellulose (30%-80%). The formulation is preferably arranged in the form of a core that comprises the active principles and, amongst others, the L-leucine, part of the talc and the silicified microcrystalline cellulose; this core is coated with a composition that contains a copolymer of methacrylic acid and ethyl acrylate.
Type:
Application
Filed:
April 23, 2008
Publication date:
December 1, 2011
Applicant:
FARMASIERRA MANUFACTURING, S.L.
Inventors:
María Rosario Fernández De Gatta García, Eduardo Jáudenes Salazar, Tomás Olleros Izard